您的位置: 首页 > 2020年7月 第51卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

探讨B超与MRI、宫腔镜联合诊断对宫腔占位性病变的临床意义

Application value of B-ultrasound、MRI and hysteroscopy in the diagnosis of uterine space occupying lesions

来源期刊: 广州医药 | 68-70 发布时间:2021-11-28 收稿时间:2025/11/13 17:44:20 阅读量:15
作者:
关键词:
B超MRI宫腔镜宫腔占位性病变
B ultrasoundMRIHysteroscopyUterine space occupying lesions
DOI:
10.3969/j.issn.1000-8535.2020.04.015
收稿时间:
2019-10-11 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨B超与MRI、宫腔镜联合诊断对宫腔占位性病变的临床意义。方法 选择2017年1月1日— 12月31日我院收治的108例疑似宫腔占位性病变患者为研究对象。所有患者均于宫腔操作前行阴道彩色多普勒超声(以下简称B超)检查、MRI检查及宫腔镜检查。与病理检查结果对比,分别分析其灵敏度、特异度。结果 108例患者中宫腔无病理变化者27例,子宫内膜息肉39例,子宫内膜增生27例,子宫黏膜下肌瘤10例,子宫内膜癌5例。B超、MRI、宫腔镜诊断灵敏度分别为72.84%、71.60%、75.31%,特异度分别为62.96%、85.19%、66.67%。B超+MRI诊断子宫黏膜下肌瘤和子宫内膜癌灵敏度100%,特异度分别为87.76%和99.03%。B超+MRI+宫腔镜诊断子宫内膜增生、子宫黏膜下肌瘤、子宫内膜癌灵敏度均为100%。结论 宫腔占位病变以良性病变居多,B超联合宫腔镜和MRI检查可提高诊断率。对子宫内膜癌高危人群应进行B超与MRI联合检查,宫腔镜定位活检仅在必要时实施。
Objective To explore the clinical significance of B-ultrasound, MRI and hysteroscopy in the diagnosis of uterine space occupying lesions. Methods 108 patients with suspected uterine space occupying lesions admitted to our hospital from January 1 to December 31 2017 were selected as the study objects. All patients were examined by vaginal color Doppler ultrasound, MRI and hysteroscopy before uterine operation. Compared with the results of pathological examination, the sensitivity and specificity were analyzed. Results Among the 108 patients, 27 had no pathological changes in uterine cavity, 39 had endometrial polyps, 27 had endometrial hyperplasia, 10 had submucous myoma, and 5 had endometrial cancer. The sensitivity of B-ultrasound, MRI and hysteroscopy were 72.84%, 71.60% and 75.31% respectively, and the specificity were 62.96%, 85.19% and 66.67% respectively. The sensitivity of B-ultrasound+MRI in the diagnosis of submucous myoma and endometrial carcinoma was 100% and the specificity was 87.76% and 99.03%, respectively. The sensitivity of B-ultrasound+MRI+hysteroscopy in the diagnosis of endometrial hyperplasia, submucous myoma and endometrial carcinoma was 100%. Conclusion Most of the uterine space occupying lesions are benign. B-ultrasound combined with hysteroscopy and MRI may improve the diagnosis rate. The high-risk group of endometrial cancer should be examined by B-ultrasound and MRI, and hysteroscopic biopsy would be performed only when necessary.
1、 刘长宏, 汪俊萍, 张云亭,等. MR扩散加权成像对宫腔良恶性病变的鉴别诊断价值[J]. 放射学实践, 2011, 26(11):1193-1196. 刘长宏, 汪俊萍, 张云亭,等. MR扩散加权成像对宫腔良恶性病变的鉴别诊断价值[J]. 放射学实践, 2011, 26(11):1193-1196.
2、 WANG H R,LINY,ZHANG X Y,et al. Transvaginal color dopplersonography combined with colposcopy for diagnosis of early stage cervical cancer and precancerous lesions[J]. J BiolRegul Homeost Agents,2018,32(1):123. WANG H R,LINY,ZHANG X Y,et al. Transvaginal color dopplersonography combined with colposcopy for diagnosis of early stage cervical cancer and precancerous lesions[J]. J BiolRegul Homeost Agents,2018,32(1):123.
3、 杨晓华.经阴道与腹部超声检查对宫腔占位性病变的诊断价值对比分析[J]. 中国药物与临床,2018,(11):1919-1920. 杨晓华.经阴道与腹部超声检查对宫腔占位性病变的诊断价值对比分析[J]. 中国药物与临床,2018,(11):1919-1920.
4、 王雪, 卢毅, 张晓夏,等. Ⅰ期子宫内膜癌与子宫内膜息肉的3.0TMRI动态增强扫描对比分析[J]. 中华医学杂志,2015, 95(3):196-199. 王雪, 卢毅, 张晓夏,等. Ⅰ期子宫内膜癌与子宫内膜息肉的3.0TMRI动态增强扫描对比分析[J]. 中华医学杂志,2015, 95(3):196-199.
5、 张晓杰.妇产科病理学[M]. 人民卫生出版社,2013. 张晓杰.妇产科病理学[M]. 人民卫生出版社,2013.
6、 夏恩兰.妇科内镜学[M]. 人民卫生出版社,2001. 夏恩兰.妇科内镜学[M]. 人民卫生出版社,2001.
7、 吴钟瑜. 新编实用妇产科超声学[M]. 天津科技翻译出版公司, 2007:89. 吴钟瑜. 新编实用妇产科超声学[M]. 天津科技翻译出版公司, 2007:89.
8、 韩艳芳,姚丽艳. B超、MRI及宫腔镜联合诊断对宫腔占位性病变的应用价值分析[J]. 中国医药导刊, 2018(1):11-15. 韩艳芳,姚丽艳. B超、MRI及宫腔镜联合诊断对宫腔占位性病变的应用价值分析[J]. 中国医药导刊, 2018(1):11-15.
9、 祝友四. MR扩散加权成像对宫腔良恶性病变的鉴别诊断价值[J]. 江西医药, 2015(7):715-717. 祝友四. MR扩散加权成像对宫腔良恶性病变的鉴别诊断价值[J]. 江西医药, 2015(7):715-717.
10、 吴汝芳. 宫腔镜检查在诊断异常子宫出血中的临床价值[J]. 中国妇幼保健,2012,27(7):1088-1090. 吴汝芳. 宫腔镜检查在诊断异常子宫出血中的临床价值[J]. 中国妇幼保健,2012,27(7):1088-1090.
11、 郑绍英,辛云淑.宫腔镜在宫腔内占位性病变临床诊治中应用价值分析[J]. 陕西医学杂志, 2016, 45(7):862-864. 郑绍英,辛云淑.宫腔镜在宫腔内占位性病变临床诊治中应用价值分析[J]. 陕西医学杂志, 2016, 45(7):862-864.
12、 柏峰,宋波,张宇,等. 彩色多普勒超声与CT联合检查在肾上腺占位性病变定位及定性的诊断价值[J]. 中国CT和MRI杂志, 2019,17(3):98-101. 柏峰,宋波,张宇,等. 彩色多普勒超声与CT联合检查在肾上腺占位性病变定位及定性的诊断价值[J]. 中国CT和MRI杂志, 2019,17(3):98-101.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录